Genetic disorders can go undiagnosed in patients leading to people enduring lengthy and invasive tests to try and find answers. Genome.One has developed a genomic test for rare and genetic conditions to assist Australians who are searching for a diagnosis.
The SPARK Co-Lab Design team, NIMo, have been on the fast track to innovation with their wearable device for the self-management of irritable bowel disease (or Non- Invasive Monitoring).
The inaugural Bridge Program is making its mark - with an abundance of partners on board such as MSD, AbbVie, Amgen, Medical Research Commercialisation Fund (MRCF), Pfizer and QUT. Eager Australian participants networked and shared their experiences at the Bridge Program’s official launch in June 2017, Residential Training Program in October 2017, and official close in November 2017.
The WA-based Centre for Entrepreneurial Research and Innovation (CERI) offers a program focused on inspiring participants to think beyond the world of academia and help them develop an entrepreneurial way of thinking.
An innovative new health service dedicated to wound care is set to improve access to specialist care for patients across the country, and is already having significant impact.
CoSec aims to build the Australian Biotech and Tech industry through providing compliance solutions in a 'one-stop-shop' format.
Exigence IT is an IT service provider specialising in the biotechnology, pharmaceutical and health sector, encompassing on-premise, cloud and hybrid systems, and providing the development, implementation and support of bespoke solutions.
New innovations in health are appearing every day. What was an industry dominated by large companies producing drugs and devices is now diversifying.
A novel mentoring program is leading the way in giving PhD students a better understanding of the commercial and industrial world of science, technology, engineering and mathematics (STEM).
Cook Medical is one of a few companies in the world to make custom (hand-sewn) aortic stents that aim to improve the outcomes for patients requiring endovascular repair worldwide and is an Australian (Brisbane) manufacturing and medical success story.
Sanofi Pasteur and the University of Melbourne are engaging in an agreement co-funding Proof-of-Concept studies - core to the University's capability and of strategic interest to Sanofi Pasteur - covering programs in infectious diseases, microbiology, and immunology, in a project running from 2014 to 2017.
Atomo Diagnostics is a specialist medical diagnostic device company that is emerging as a leading innovator in the field of rapid diagnostic testing.
The Medical Device Partnering Program (MDPP) at Flinders University fosters collaborations between inventors, researchers, industry, manufacturers, end-users and government, to help develop cutting-edge medical devices.
Startup SpeeDx - a Sydney based company founded in 2009 - have developed a new clinical testing technology finding a solution to the growing threat of drug resistance.